The economic burden of diarrheal disease in a tertiary level hospital, Gauteng, South Africa

Journal of Infectious Diseases

Volumn 202, Issue SUPPL. 1, 2010, Pages

  MacIntyre, Una E ^a   De Villiers, Francois P R ^b  

^a Institute for Human   (South Africa)

^b SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G;

ARTICLE; COST OF ILLNESS; DIAGNOSTIC TEST; DIARRHEA; DRUG COST; ECONOMIC ASPECT; GROUPS BY AGE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; SOUTH AFRICA;

CHILD, PRESCHOOL; COST OF ILLNESS; DIARRHEA; FEMALE; HOSPITAL COSTS; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; ROTAVIRUS INFECTIONS; SOUTH AFRICA;

EID: 77955706715     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653560     Document Type: Article

References (26)

1. Snyder JD, Merson M.H. The magnitude of the global problem of acute diarrheal disease: a review of active surveillance data. BullWorld Health Organ 1982; 60:605-613.
2. Bern C, Martines J, de Zoysa I, Glass R. The magnitude of the global problem of diarrheal disease: a ten-year update. Bull World Health Organ 1992; 70:705-714.
3. Kosek M, Bern C, Guerrant R.L. The global burden of diarrheal disease, as estimated from studies published between 1992 and 2000. BullWorld Health Organ 2003; 81:197-204.
4. Keusch GT, Fontaine O, Bhargava A et al Diarrheal disease. In: Jamison DT, Breman JG, Measham AR et al., eds. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press and the World Bank, 2006.
5. Statistics South Africa. Mortality and causes of death in South Africa, 2005: Findings from death notification. Statistical Release P0309.3. 2005. http://www.statssa.gov.za. Accessed 30 October 2008.
6. Murray C, Lopez A. Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health, World Health Organisation, World Bank, 1996.
7. Parashar UD, Hummelman EG, Bressee JS, Millar MA, Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003; 9:565-572.
8. Widdowson M-A, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass R.I. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684-697.
9. Fischer TK, Viboud C, Parashar U et al Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis 2007; 195:1117-1125.
10. Bresee JS, Hummelman E, Nelson EAS, Glass R.I. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 2005; 192(Suppl 1):S1-S5.
11. Mwenda JM, Armah G, Page N et al Update on the AFR rotavirus surveillance network (AFR RSN). African Rotavirus Surveillance Newsletter 2008; 1:1-3. http://www.path.org/vaccineresources/files/AFR-rotavirus-surv-newsletter-Jan08. pdf. Accessed 7 November 2008.
12. Vesikari T, Van Damme P, Giaquinto C et al European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenerology, Hepatology, and Nutrition Evidence-based recommendations for rotavirus vaccination in Europe. J Pediatr Gastroenterol Nutr 2008; 46:615-618.
13. Government Gazette. Notice 1321 of 2006. No 29213. Pretoria: Government Printer, 2006.
14. Steele AD, De Vos B, Tumbo J et al Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine 2008 (Epub ahead of print).
15. Tshabalala-Msimang M. Speaking notes for the Minister of Health of the Republic of South Africa on the work of WHO in the African Region: 2006-2007, Biennial Report of the Regional Director. 1 September 2008. http://www.doh.gov. za/docs/sp/2008/sp0901.html. Accessed 23 November 2008.
16. Department of Health. Uniform patient fee schedule for patients attending public hospitals. User Guide-UPFS (with revised 2004 tariffs). 2004. http://www.doh.gov.za/programmes/upfs/index.html. Accessed 10 January 2005.
17. Dean AG, Garner TG, Sangam S et al Epi Info 2000. A database, and statistics program for public health professionals. Atlanta: Centers for Disease Control and Prevention, 2000.
18. Evans DB, Edejer TT-T, Adam T, Lim S.S.WHOChoosing Interventions that are Cost Effective (CHOICE) Millennium Development Goals Team. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ 2005; 331: 1137-1140.
19. Nelson EAS, Tam JS, Yu L-M et al Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis 2005; 192(Suppl 1):S64-S70.
20. Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005; 192(Suppl1):S133-S145.
21. Fischer TK, Anh DD, Cat NDL et al Health care costs of diarrheal disease and estimates of the cost effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005; 192:1720-1726.
22. Giaquinto C, Van Damme P, Huet F et al Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis 2007; 195(Suppl 1):S26-S34.
23. De Villiers FP.R. Practical management of paediatric emergencies. 4th ed. Pretoria: Oasis Purple, 2004.
24. Isakbaeva ET, Musabaev E, Antil L et al Rotavirus disease in Uzbekistan: cost effectiveness of a new vaccine. Vaccine 2007; 25:373-380.
25. Statistics South Africa. Labour Force Survey. September 2005. Statistical Release P0210. 2005. http://www.statssa.gov.za. Accessed 8 March 2006.
26. Ho AM-H, Nelson EAS, Walker D.G. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong Government perspective. Arch Dis Child 2008; 93:52-58.